Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia

BACKGROUND: While current chemotherapy has increased cure rates for children with acute lymphoblastic leukaemia (ALL), the largest number of relapsing patients are still stratified as medium risk (MR) at diagnosis (50–60%). This highlights an opportunity to develop improved relapse-prediction models...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Alruwetei, Abdulmohsen M., Bendak, Katerina, Yadav, Babasaheb D., Carol, Hernan, Evans, Kathryn, Mayoh, Chelsea, Sutton, Rosemary, Marshall, Glenn M., Lock, Richard B.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462974/
https://ncbi.nlm.nih.gov/pubmed/32536690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0933-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars